Rockwell Medical, Inc.

NasdaqCM:RMTI Stock Report

Market Cap: US$44.5m

Rockwell Medical Management

Management criteria checks 2/4

Rockwell Medical's CEO is Mark Strobeck, appointed in Jul 2022, has a tenure of 1.75 years. total yearly compensation is $1.05M, comprised of 53.7% salary and 46.3% bonuses, including company stock and options. directly owns 0.074% of the company’s shares, worth $32.77K. The average tenure of the management team and the board of directors is 2.2 years and 7.5 years respectively.

Key information

Mark Strobeck

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage53.7%
CEO tenure1.8yrs
CEO ownership0.07%
Management average tenure2.2yrs
Board average tenure7.5yrs

Recent management updates

Recent updates

Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Feb 06
Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Dec 25
Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Oct 11
Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Jun 02
Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

Oct 25
Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Sep 02
An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Rockwell Medical Q2 Earnings Preview

Aug 12

Rockwell Medical: Triferic Remains Key Despite Sluggish Growth Profile

Mar 02

Rockwell Medical: Down But By No Means Out

Oct 05

Rockwell Medical pops 6% on licensing deal for Triferic AVNU in Turkey

Jun 08

Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Mar 08
Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

Feb 10
Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?

Jan 18
How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?

Dosing underway in Rockwell Medical's late-stage Triferic trial in China

Jan 13

Rockwell Medical: Heavily Oversold Company With Big Potential

Jan 11

This Insider Has Just Sold Shares In Rockwell Medical, Inc. (NASDAQ:RMTI)

Dec 21
This Insider Has Just Sold Shares In Rockwell Medical, Inc. (NASDAQ:RMTI)

Rockwell Medical, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 09

CEO Compensation Analysis

How has Mark Strobeck's remuneration changed compared to Rockwell Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$566k

-US$9m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$978kUS$267k

-US$19m

Compensation vs Market: Mark's total compensation ($USD1.05M) is above average for companies of similar size in the US market ($USD677.87K).

Compensation vs Earnings: Mark's compensation has increased whilst the company is unprofitable.


CEO

Mark Strobeck (52 yo)

1.8yrs

Tenure

US$1,054,169

Compensation

Dr. Mark Strobeck, Ph D., serves as Independent Director at Windtree Therapeutics, Inc. since June 2023. He has served as the President, Chief Executive Officer and Director Rockwell Medical, Inc. since Ju...


Leadership Team

NamePositionTenureCompensationOwnership
Mark Strobeck
President1.8yrsUS$1.05m0.074%
$ 32.8k
Jesse Neri
Senior Vice President of Financeless than a yearUS$453.18kno data
Megan Timmins
Executive VP2.7yrsUS$660.29k0.038%
$ 16.8k
James McCarthy
Senior Vice President of Business & Corporate Development5.6yrsno datano data
Timothy Chole
Senior Vice President of Sales & Marketing4.3yrsno datano data
Heather Hunter
Senior VP & Chief Corporate Affairs Officer1.6yrsno datano data
Jason Finkelstein
Investor Relations Representativeno datano datano data

2.2yrs

Average Tenure

50yo

Average Age

Experienced Management: RMTI's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Strobeck
President1.8yrsUS$1.05m0.074%
$ 32.8k
John Cooper
Independent Director6.6yrsUS$142.27k0.033%
$ 14.6k
Robert Radie
Independent Chairman4.1yrsUS$170.00k0.026%
$ 11.7k
Anatole Besarab
Member of Medical Advisory Board18.4yrsno datano data
Rajiv Agarwal
Member of Scientific Advisory Board18.4yrsno datano data
Allen Nissenson
Independent Director3.8yrsUS$127.94k0.023%
$ 10.3k
Iain MacDougall
Member of Scientific Advisory Board13.7yrsno datano data
Alvin Crumbliss
Member of Scientific Advisory Board13yrsno datano data
Francesco Locatelli
Member of Scientific Advisory Board11.3yrsno datano data
Mark Ravich
Independent Director6.8yrsUS$128.29k0.15%
$ 68.7k
Gary Brittenham
Member of Scientific Advisory Board8.3yrsno datano data
Andrea Smiley
Independent Director3.3yrsUS$130.56k0.021%
$ 9.4k

7.5yrs

Average Tenure

62yo

Average Age

Experienced Board: RMTI's board of directors are considered experienced (7.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.